Out-licensing
Up-to-date access to technology licensing opportunities worldwide.
- Out-licensing
- Browse
Licensing opportunities
A rapid and automated method for discovering potential drugs for the treatment of sickle cell anemia, using a combination of laser photolysis and statistical processing of digital images. More
Use of substituted or modified C60 fullerenes for the prevention or treatment of thrombosis, peripheral arterial occlusion, and catheter obstruction. More
Easy detection of haemoglobinopathies through use of MSMS. More
BiliSuit – a Fiber optic LED form fitting garment for treatment of infant hyperbilirubinemia (09-03)
Portable phototherapy device to treat jaundiced infants More
Genetic cloning and sequencing of a novel IL-17 receptor-related gene More
NexMed is developing RayVaTM, a topical treatment for Raynaud’s syndrome and incorporates alprostadil with the NexACT® proprietary permeation enhancer (DDAIP.HCL). More
Related Reports
Market Research Reports provided by reports.innovaro.com
Nov 2010 - 330 pages - $1,495
Dec 2010 - 42 pages - $1,000
Mar 2011 - 6 pages - $500
Nov 2010 - 40 pages - $500
May 2011 - 15 pages - $250
Mar 2010 - 145 pages - $3,500
May 2011 - 396 pages - $2,265
May 2011 - 15 pages - $250
May 2011 - 15 pages - $250
Jan 2010 - $75
Your selection
Browse By
- Industry sector
- Animal health
- Biotechnology
- Diagnostic
- Drug delivery
- Drug discovery
- Medical device
- Pharmaceutical
- Research tools
- Therapeutic target
- Blood disorders (other)
- Hemolytic uremic syndrome
- Hemophilia
- Myelodysplastic syndrome
- Development phase
- Early Stage
- Preclinical
- Phase I
- Phase I/II
- Phase II
- Phase III
- Phase III/IV
- Preregistration
- Registered
© Copyright 1998-2012 Innovaro Europe Ltd 
All rights reserved. Terms and Conditions | Contact us